These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36704346)

  • 1. A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction.
    Zheng P; Long Z; Gao A; Lu J; Wang S; Zhong C; Lai H; Guo Y; Wang K; Fang C; Mao X
    Front Genet; 2022; 13():1110799. PubMed ID: 36704346
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer.
    Wang K; Zhong W; Long Z; Guo Y; Zhong C; Yang T; Wang S; Lai H; Lu J; Zheng P; Mao X
    Front Mol Biosci; 2021; 8():775304. PubMed ID: 34926580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer.
    Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J
    Front Oncol; 2022; 12():876531. PubMed ID: 35860569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y; Zhang Q; Zhang H; Kong F
    Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.
    Cheng B; He Q; Cheng Y; Yang H; Pei L; Deng Q; Long H; Zhu L; Jiang R
    Front Genet; 2019; 10():1402. PubMed ID: 32117427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
    Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
    Front Genet; 2022; 13():975905. PubMed ID: 36313456
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy.
    Luo C; He S; Zhang H; He S; Qi H; Wei A
    Front Genet; 2022; 13():727307. PubMed ID: 35186021
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer.
    Jiang S; Li Z; Dou R; Lin Z; Zhang J; Zhang W; Chen Z; Shen X; Ji J; Qu M; Wang Y; Li M; Gao X
    Front Genet; 2022; 13():976850. PubMed ID: 36561322
    [No Abstract]   [Full Text] [Related]  

  • 15. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
    Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
    Front Surg; 2021; 8():665115. PubMed ID: 34136527
    [No Abstract]   [Full Text] [Related]  

  • 17. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
    Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
    Liu H; Chen C; Liu L; Wang Z
    Front Genet; 2022; 13():1081478. PubMed ID: 36685868
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma.
    Yang L; Wu Y; Xu H; Zhang J; Zheng X; Zhang L; Wang Y; Chen W; Wang K
    Front Oncol; 2021; 11():775583. PubMed ID: 35111670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database.
    He Y; Zhang J; Chen Z; Sun K; Wu X; Wu J; Sheng L
    Front Surg; 2022; 9():923473. PubMed ID: 37255653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.